{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T01:04:21Z","timestamp":1771722261062,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.rmed.2020.106081","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T20:37:32Z","timestamp":1593808652000},"page":"106081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Corticosteroid refractory sarcoidosis"],"prefix":"10.1016","volume":"171","author":[{"given":"Chananya","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmed.2020.106081_bib1","first-page":"280","article-title":"The indications for the treatment of sarcoidosis : well's Law","volume":"34","author":"Baughman","year":"2017","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.rdc.2015.08.012","article-title":"Corticosteroids in sarcoidosis","volume":"42","author":"Judson","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAJ.0b013e3181b97635","article-title":"Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations","volume":"339","author":"McKinzie","year":"2010","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.08-1347","article-title":"The treatment of lupus pernio: results of 116 treatment courses in 54 patients","volume":"135","author":"Stagaki","year":"2009","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.rmed.2008.08.016","article-title":"Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis","volume":"103","author":"Sodhi","year":"2009","journal-title":"Respir. Med."},{"issue":"16","key":"10.1016\/j.rmed.2020.106081_bib6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","article-title":"Diagnosis and management of neurological sarcoidosis","volume":"157","author":"Lower","year":"1997","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.rmed.2020.106081_bib7","first-page":"125","article-title":"Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis","volume":"13","author":"Kikuchi","year":"2016","journal-title":"J. Cardiol. Cases"},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib8","first-page":"97","article-title":"Management of refractory ventricular tachycardia due to cardiac sarcoidosis-A biologic approach","volume":"5","author":"Theodore","year":"2019","journal-title":"Heart Rhythm Case Rep."},{"key":"10.1016\/j.rmed.2020.106081_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2019.02.025","article-title":"Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis","author":"Okada","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.rmed.2020.106081_bib10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.rmed.2020.106081_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/cei.12942","article-title":"Sarcoidosis extent relates to molecular variability","volume":"188","author":"Monast","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.rmed.2020.106081_bib13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib14","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2020.106081_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","article-title":"Toxicity risk from glucocorticoids in sarcoidosis patients","volume":"132","author":"Khan","year":"2017","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2020.106081_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2020.106081_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MAJ.0b013e3181fe3eb2","article-title":"Impact of systemic corticosteroids on healthcare utilization in patients with sarcoidosis","volume":"341","author":"Ligon","year":"2011","journal-title":"Am. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib18","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2020.106081_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.00195010","article-title":"Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis","author":"Sahoo","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"3 Pt 1","key":"10.1016\/j.rmed.2020.106081_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0190-9622(90)70246-E","article-title":"Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas","volume":"23","author":"Jones","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.rmed.2020.106081_bib21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"16","key":"10.1016\/j.rmed.2020.106081_bib22","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.21705","article-title":"Glucocorticoid use, other associated factors, and the risk of tuberculosis","volume":"55","author":"Jick","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.rmed.2020.106081_bib24","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/acr.22628","article-title":"Herpes Zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease-modifying antirheumatic drugs","volume":"67","author":"Pappas","year":"2015","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.rmed.2020.106081_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.04.033","article-title":"When the game changes: guidance to adjust sarcoidosis management during the COVID-19 pandemic","author":"Sweiss","year":"2020","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2020.106081_bib26","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rmed.2020.106081_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1710-1492-7-13","article-title":"Adrenal suppression: a practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy","volume":"7","author":"Ahmet","year":"2011","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"10","key":"10.1016\/j.rmed.2020.106081_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4065\/81.10.1361","article-title":"Psychiatric adverse effects of corticosteroids","volume":"81","author":"Warrington","year":"2006","journal-title":"Mayo Clin. Proc."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","article-title":"Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care","volume":"169","author":"Fardet","year":"2012","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/07357908909041378","article-title":"Corticosteroids in cancer: neuropsychiatric complications","volume":"7","author":"Stiefel","year":"1989","journal-title":"Canc. Invest."},{"issue":"4","key":"10.1016\/j.rmed.2020.106081_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0165-0327(83)90022-8","article-title":"Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature","volume":"5","author":"Lewis","year":"1983","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","article-title":"Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study","volume":"104","author":"Schutt","year":"2010","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2020.106081_bib33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/BOR.0000000000000489","article-title":"Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations","volume":"30","author":"West","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2020.106081_bib35","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/acr.23279","article-title":"American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"3","key":"10.1016\/j.rmed.2020.106081_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.04322.x","article-title":"Prevention and treatment of systemic glucocorticoid side effects","volume":"49","author":"Moghadam-Kia","year":"2010","journal-title":"Int. J. Dermatol."},{"issue":"7","key":"10.1016\/j.rmed.2020.106081_bib37","first-page":"2350","article-title":"Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test","volume":"83","author":"Erturk","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"25 Suppl 2","key":"10.1016\/j.rmed.2020.106081_bib38","first-page":"S49","article-title":"ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Goff","year":"2013","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2020.106081_bib39","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jcjd.2013.01.009","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction","volume":"37","author":"Cheng","year":"2013","journal-title":"Can. J. Diabetes"},{"issue":"6","key":"10.1016\/j.rmed.2020.106081_bib40","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2010-2729","article-title":"Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD","volume":"96","author":"Burt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.rmed.2020.106081_bib41","first-page":"188","article-title":"Clinical aspects of ocular sarcoidosis","volume":"10","author":"Ohara","year":"2005","journal-title":"Eur. Respir. J. Monogr."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.rmed.2020.106081_bib43","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/00004872-199917070-00022","article-title":"Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study","volume":"17","author":"Waeber","year":"1999","journal-title":"J. Hypertens."},{"issue":"8","key":"10.1016\/j.rmed.2020.106081_bib44","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin. Therapeut."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1524-4733.2003.65269.x","article-title":"Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes","volume":"6","author":"Cramer","year":"2003","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.rmed.2020.106081_bib46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2133.2010.09877.x","article-title":"Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy","volume":"163","author":"Arena","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.rmed.2020.106081_bib47","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.crohns.2014.08.013","article-title":"Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in inflammatory bowel disease","volume":"8","author":"Mountifield","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"3","key":"10.1016\/j.rmed.2020.106081_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/thx.51.3.323","article-title":"Compliance with oral corticosteroids during steroid trials in chronic airways obstruction","volume":"51","author":"Hatton","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2020.106081_bib49","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1038\/npjpcrm.2015.26","article-title":"Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study","volume":"25","author":"Cooper","year":"2015","journal-title":"NPJ Prim. Care Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib50","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/cen.12991","article-title":"Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information","volume":"84","author":"Chapman","year":"2016","journal-title":"Clin. Endocrinol."},{"issue":"9","key":"10.1016\/j.rmed.2020.106081_bib51","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/0961203307080635","article-title":"Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: a study with a questionnaire","volume":"16","author":"Nived","year":"2007","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.rmed.2020.106081_bib52","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00467-004-1791-7","article-title":"Triamcinolone acetonide: a new management of noncompliance in nephrotic children","volume":"20","author":"Ulinski","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.rmed.2020.106081_bib53","series-title":"Depot Intramuscular Triamcinolone for the Treatment of Sarcoidosis","author":"Kravitz","year":"2011"},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2020.106081_bib56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/PAS.0b013e3182785a2d","article-title":"End-stage sarcoid lung disease is distinct from usual interstitial pneumonia","volume":"37","author":"Xu","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17476348.2017.1281745","article-title":"Strategies for identifying pulmonary sarcoidosis patients at risk for severe or chronic disease","volume":"11","author":"Judson","year":"2017","journal-title":"Expet Rev. Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/RLU.0b013e3182335f9b","article-title":"F-18 FDG PET\/CT for detecting bone and bone marrow involvement in sarcoidosis patients","volume":"37","author":"Mostard","year":"2012","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.rmed.2020.106081_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.rmed.2018.04.015","article-title":"Clinical features of sarcoidosis associated pulmonary hypertension: results of a multi-national registry","volume":"139","author":"Baughman","year":"2018","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib60","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1378\/chest.129.5.1246","article-title":"Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis","volume":"129","author":"Handa","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib61","first-page":"154","article-title":"Clinical bronchiectasis complicating pulmonary sarcoidosis: case series of seven patients","volume":"19","author":"Lewis","year":"2002","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"12","key":"10.1016\/j.rmed.2020.106081_bib62","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.rmed.2013.10.014","article-title":"Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients","volume":"107","author":"Baughman","year":"2013","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib63","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.12-1784","article-title":"A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma","volume":"143","author":"Kravitz","year":"2013","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2020.106081_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02396-2016","article-title":"Chronic pulmonary aspergillosis complicating sarcoidosis","volume":"49","author":"Uzunhan","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib65","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MCP.0000000000000082","article-title":"Worsening of pulmonary sarcoidosis","volume":"20","author":"Judson","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"4","key":"10.1016\/j.rmed.2020.106081_bib66","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1378\/chest.15-0584","article-title":"Interrelationship between sleep-disordered breathing and sarcoidosis","volume":"148","author":"Lal","year":"2015","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib67","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1378\/chest.121.2.625","article-title":"Oral corticosteroids increase esophageal acid contact times in patients with stable asthma","volume":"121","author":"Lazenby","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.106081_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","article-title":"The three tiers of screening for sarcoidosis organ involvement","volume":"113","author":"Judson","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2020.106081_bib69","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment","volume":"126","author":"Tavee","year":"2017","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2020.106081_bib70","first-page":"206","article-title":"MRI of the wrist joint: \"granulomatous tenovaginitis of the sarcoidosis type\"--a rare cause of carpal tunnel syndrome","volume":"48","author":"Kersting-Sommerhoff","year":"1995","journal-title":"Rontgenpraxis"},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"Drent","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib72","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/ajrccm.163.2.2004177","article-title":"Depression in sarcoidosis","volume":"163","author":"Chang","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2020.106081_bib73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000314225","article-title":"Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment","volume":"80","author":"Elfferich","year":"2010","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib74","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1183\/09031936.00156314","article-title":"Negative clinical trials in sarcoidosis: failed therapies or flawed study design?","volume":"44","author":"Moller","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/CPM.0000000000000136","article-title":"Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach","volume":"23","author":"Korsten","year":"2016","journal-title":"Clin. Pulm. Med."},{"issue":"7","key":"10.1016\/j.rmed.2020.106081_bib76","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis","volume":"71","author":"Dixon","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2020.106081_bib77","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.rmed.2020.106081_bib78","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1001\/jama.1992.03480060078034","article-title":"Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital","volume":"267","author":"Sepkowitz","year":"1992","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.rmed.2020.106081_bib79","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.semarthrit.2016.11.006","article-title":"Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): a nested case-control analysis","volume":"46","author":"Wilson","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib80","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/kem311","article-title":"Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis","volume":"47","author":"Panoulas","year":"2008","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib81","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2020.106081_bib82","first-page":"46","article-title":"Efficacy results of a 52-week trial of adalimumab in the treatment of refractory sarcoidosis","volume":"31","author":"Sweiss","year":"2014","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"5","key":"10.1016\/j.rmed.2020.106081_bib83","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2020.106081_bib84","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120302213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120302213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:02:27Z","timestamp":1760616147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120302213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":84,"alternative-id":["S0954611120302213"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106081","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroid refractory sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106081"}}